» Articles » PMID: 22632633

Safranal Enhances Non-rapid Eye Movement Sleep in Pentobarbital-treated Mice

Overview
Specialties Neurology
Pharmacology
Date 2012 May 29
PMID 22632633
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: Safranal (2,6,6-trimethyl-1,3-cyclohexadiene-1-carboxaldehyde, C(10) H(14) O) is an active ingredient in the saffron, which is used in traditional medicine. It has been reported to have sedative and anti-epileptic effects, but its hypnotic effects remain uncertain. The aim of this study was to evaluate effects of safranal on sleep-wake cycle.

Methods: We established hypnotic-model mice treated with a low dose of pentobarbital 20 mg/kg, and administered different doses of safranal, vehicle, or diazepam. The change of sleep-wake cycle was assessed by sleep recording and c-Fos expression in the brain was analyzed by immunohistochemistry.

Results: Safranal increased the duration of non-rapid eye movement (NREM) sleep, shortened NREM sleep latency, and enhanced the delta power activity of NREM sleep. Immunohistochemical evaluation revealed that safranal increased c-Fos expression in the ventrolateral preoptic nucleus (VLPO), one of the putative sleep centers, and decreased it in the arousal histaminergic tuberomammillary nuclei (TMN).

Conclusion: These findings indicate that safranal enhances NREM sleep in pentobarbital-treated mice. The hypnotic effects of safranal may be related to the activation of the sleep-promoting neurons in the VLPO and the simultaneous inhibition of the wakefulness-promoting neurons in the TMN, suggesting that safranal may be a hypnotic substance.

Citing Articles

GABALAGEN Facilitates Pentobarbital-Induced Sleep by Modulating the Serotonergic System in Rats.

Ye M, Rheu K, Lee B, Shim I Curr Issues Mol Biol. 2024; 46(10):11176-11189.

PMID: 39451543 PMC: 11505973. DOI: 10.3390/cimb46100663.


Application of the relative molar sensitivity method using GC-FID to quantify safranal in saffron (Crocus sativus L.).

Masumoto N, Ohno T, Suzuki T, Togawa T, Sugimoto N J Nat Med. 2023; 77(4):829-838.

PMID: 37450205 DOI: 10.1007/s11418-023-01724-8.


Crocus Sativus for Insomnia: A Systematic Review and Meta-Analysis.

Munirah M, Norhayati M, Noraini M Int J Environ Res Public Health. 2022; 19(18).

PMID: 36141931 PMC: 9517076. DOI: 10.3390/ijerph191811658.


Ganoderma lucidum promotes sleep through a gut microbiota-dependent and serotonin-involved pathway in mice.

Yao C, Wang Z, Jiang H, Yan R, Huang Q, Wang Y Sci Rep. 2021; 11(1):13660.

PMID: 34211003 PMC: 8249598. DOI: 10.1038/s41598-021-92913-6.


Effects of Saffron Extract on Sleep Quality: A Randomized Double-Blind Controlled Clinical Trial.

Pachikian B, Copine S, Suchareau M, Deldicque L Nutrients. 2021; 13(5).

PMID: 33925432 PMC: 8145009. DOI: 10.3390/nu13051473.


References
1.
Zhao X, Cui X, Chu Q, Chen B, Wang X, Lin Z . Potentiating effects of L-type Ca(2+) channel blockers on pentobarbital-induced hypnosis are influenced by serotonergic system. J Neural Transm (Vienna). 2006; 113(10):1395-402. DOI: 10.1007/s00702-005-0422-1. View

2.
Huang Z, Urade Y, Hayaishi O . The role of adenosine in the regulation of sleep. Curr Top Med Chem. 2011; 11(8):1047-57. DOI: 10.2174/156802611795347654. View

3.
. Potentiation of pentobarbitone sleeping time by chloroquine in the rat. Arch Int Pharmacodyn Ther. 1980; 243(2):192-6. View

4.
Huang Z, Urade Y, Hayaishi O . Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr Opin Pharmacol. 2006; 7(1):33-8. DOI: 10.1016/j.coph.2006.09.004. View

5.
Hosseinzadeh H, Sadeghnia H . Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine. 2006; 14(4):256-62. DOI: 10.1016/j.phymed.2006.03.007. View